SCHEMBL7095853

SCHEMBL7095853

CCN(CCCCCN(CC)S(=O)(=O)c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.60
HTT P42858 4/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
SERPINE1 P05121 1/20 0.54
ALDH1A1 P00352 2/20 0.54
GLA P06280 1/20 0.53
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MCHR1 Q99705 1/20 0.51
HTR7 P34969 1/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7096588 1.00 CNR2 (0.60) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7091892 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7092599 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7091255 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7097469 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7092601 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7096609 0.98 CNR2 (0.59) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7092691 0.96 CNR2 (0.57) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL6490141 0.95 CNR2 (0.67) CNR2HTTLMNASMN1; SMN2SERPINE1
SCHEMBL7201208 0.95 CNR2 (0.56) CNR2HTTLMNASMN1; SMN2SERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627399-B1 Using compound of given formula as accelerator RIKEN (JP) 2003-09-30 US disclosed
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20030073202-A1 RNA polymerase transcription promoter and nucleic acid sequencing method IWATA MASAAKI (JP) 2003-04-17 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed
EP-1061130-A1 RNA POLYMERASE TRANSCRIPTION PROMOTERS AND METHOD FOR DETERMINING BASE SEQUENCE Riken (JP) 2000-12-20 EP disclosed